Items Tagged ‘CD20-positive’

September 26th, 2016

Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

By

Acccording to results recently published in the New England Journal of Medicine, young adults with CD20-positive, Philadelphia chromosome  (PH)-negative acute lymphoblastic leukemia (ALL), experience survival benefits with the addition of Rituxan® (rituximab) to standard chemotherapy. ALL in children is a malignant disease, or cancer of the blood, characterized by the rapid uncontrolled growth of abnormal, […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, CD20-positive, Childhood Acute Lymphoblastic Leukemia, children, Leukemia, News, Ph-negative, Philadelphia chromosome (PH)-negative acute lymphoblastic leukemia


December 16th, 2015

Addition of Rituxan Improves Outcomes in Some Acute Lymphoblastic Leukemias

By

The addition of Rituxan (rituximab) to standard chemotherapy-based regimens improves outcomes among patients with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that is CD20-positive. These results were reported at a plenary session at the 2015 annual meeting of the American Society of Hematology in Orlando, Florida. B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is an aggressive type […]

View full entry

Tags: Acute Lymphoblastic Leukemia, B-cell precursor acute lymphoblastic leukemia, BCP-ALL, CD20-positive, Leukemia, News, riruximab, rituxan